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Abstract
Background: Clinical practice and clinical research has made a concerted effort to move beyond the use of clinical
indicators alone and embrace patient focused care through the use of patient reported outcomes such as health-
related quality of life. However, unless patients give consistent consideration to the health states that give meaning
to measurement scales used to evaluate these constructs, longitudinal comparison of these measures may be
invalid. This study aimed to investigate whether patients give consideration to a standard health state rating scale
(EQ-VAS) and whether consideration of good and poor health state descriptors immediately changes their self-
report.
Methods: A randomised crossover trial was implemented amongst hospitalised older adults (n = 151). Patients
were asked to consider descriptions of extremely good (Description-A) and poor (Description-B) health states. The
EQ-VAS was administered as a self-report at baseline, after the first descriptors (A or B), then again after the
remaining descriptors (B or A respectively). At baseline patients were also asked if they had considered either EQ-
VAS anchors.
Results: Overall 106/151 (70%) participants changed their self-evaluation by ≥5 points on the 100 point VAS, with
a mean (SD) change of +4.5 (12) points (p < 0.001). A total of 74/151 (49%) participants did not consider the best
health VAS anchor, of the 77 who did 59 (77%) thought the good health descriptors were more extreme (better)
then they had previously considered. Similarly 85/151 (66%) participants did not consider the worst health anchor
of the 66 who did 63 (95%) thought the poor health descriptors were more extreme (worse) then they had
previously considered.
Conclusions: Health state self-reports may not be well considered. An immediate significant shift in response can
be elicited by exposure to a mere description of an extreme health state despite no actual change in underlying
health state occurring. Caution should be exercised in research and clinical settings when interpreting subjective
patient reported outcomes that are dependent on brief anchors for meaning.
Trial Registration: Australian and New Zealand Clinical Trials Registry (#ACTRN12607000606482) http://www.anzctr.
org.au
Background
Over past decades, clinical practice and clinical research
has made a concerted effort to move beyond the use of
clinical indicators alone and embrace patient focused
care[1]. Along this line, the evaluation of health-related
quality of life (HRQoL) has great benefit in revealing
how each patient views their own health state. Subjec-
tive HRQoL evaluation has particular importance
amongst patient groups suffering from chronic, degen-
erative or terminal conditions where the aim of health
interventions are to improve quality of life rather than
for a curative effect[2,3]. It is not surprising then, that
the use of generic HRQoL evaluation instruments, such
as the Euroqol-5D (EQ-5D), have become increasingly
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and as a primary instrument for economic evaluation
through cost-utility analysis[4].
Concerns have been raised about the validity of mak-
ing comparisons between HRQoL evaluations taken at
different time points as change in ones understanding
or perception of the HRQoL construct may occur
between assessments [5-8]. If a respondent were to
change their understanding of what components are
included in the construct of HRQoL (reconceptualisa-
tion), or the relative importance of certain components
of HRQoL in relation to the other components (reprior-
itisation) or change their internal perception of the rela-
tive value of certain health states in relation to others
(recalibration), then each evaluation may not necessarily
be measuring the same concept, with the same value
system on the same scale despite consistent use of the
same patient reported outcome [5-7]. This phenomenon
has been given the term ‘response shift.’
Response shift is generally considered to be part of
naturally occurring adaptive processes and may help
individuals adjust to living with poor health states and
t h u sm a yb ead e s i r a b l ec o p i n gm e c h a n i s mo re v e nt h e
goal of some treatments[6,7,9-11]. However, it also
threatens to invalidate comparisons of pre and post
intervention assessments or assessments taken over mul-
tiple time points in the trajectory of a chronic disease,
despite use of a standardised instrument[6,7,9,11-13].
For this reason a number of methods to detect response
shift, such as the ‘then-test’ (a retrospective report of a
previous health state from the respondent’s current per-
spective)[5,8,11,14,15] and ‘structural equation model-
ling’ (mathematical modelling to detect changes in
factor solutions and variance-covariance matrices over
time)[12,15,16] have been developed to evaluate
response shift between assessments. However, these
methods can often be time consuming, complex or bur-
densome on patients[5,7,11,15]. Detailed discussion of
methods to detect response shift has previously been
described[5,7,11,15,17].
It may not be possible (or desirable) to eliminate adap-
tive processes that contribute to response shift[5,7,11].
However, a potentially preventable (and undesirable)
response shift artefact may occur as a result of subjective
HRQoL appraisal processes. This may occur when a
respondent does not give consistent consideration to ques-
tions used to evaluate their HRQoL at each assessment
point. Subjective scales dependent on brief anchor descrip-
tions to give meaning to the scale may be particularly
prone to inconsistent consideration of the instrument, as a
change in consideration of one or both anchors may lead
to a substantial difference in response[11].
The EQ-VAS is the health state rating scale from the
popular EQ-5D generic health-related quality of life
instrument. The EQ-VAS includes a 100 point visual
analogue rating scale with a bottom anchor of ‘worst
imaginable health’ a n dat o pa n c h o ro f‘best imaginable
health’[18]. The EQ-VAS has favourable empirical evi-
dence supporting its sensitivity to change, validity and
reliability[19-27]. However, an investigation of EQ-VAS
use in rating multiple hypothetical health states found
that the rating given to common moderate health states
w e r ea f f e c t e db yt h ec o n t e x ti nw h i c ht h e yw e r ep r e -
sented[28]. It was noted that moderate health states
were assigned lower values when presented in the con-
text of more mild (better) health states and assigned
higher values when presented in the context of more
severe (worse) health states [28]. This is not an isolated
finding for rating scales[29].
There is also evidence from other fields that framing a
question to focus on positive or negative attributes can
yield different responses despite no difference in logical
meaning[30-33]. Empirical investigations of the framing
effect generally suggest respondents demonstrate prefer-
ence for an option with a positive valence rather than
negative[31-33]. A simple example includes respondents
reporting ground mince as ‘tastier’ when labelled as 75%
lean, rather than 25% fat[34]. Framing effects have been
applied in a wide range of fields including politics, con-
sumer behaviour and health[30-34].
Respondents completing health state rating scales (like
the EQ-VAS) are generally not required to rate multiple
hypothetical health states and intentional framing tech-
niques are not routinely employed. However, a similar
unintentional reference type bias may occur due to
social comparisons or other life events[11].
Consider a 65 year old woman who is receiving treat-
ment in hospital after suffering a stroke. She may rate
her health at this time with reference to surrounding
hospital patients who are very unwell. This patient may
report her health as 60 out of 100 on the EQ-VAS
immediately prior to discharge from an inpatient rehabi-
litation facility; after considering how much better she is
than other patients in very poor health states (near the
bottom of the scale). However, immediately after dis-
charge into the care of family, this patient may report
her health as 45 out of 100 on the EQ-VAS after con-
sidering how much worse her health is in comparison to
healthy peers in the community (who may be near the
top of the scale). An independent observer may infer
that a decline in health state of 15 points has occurred
(despite potentially no reduction in the patients’ actual
health or HRQoL).
Inconsistent consideration of subjective patient
reported outcomes may cause a patient to paradoxically
report a change when no change has occurred, or a dis-
proportionate change than that which has actually taken
place. An inaccurate representation of change due to
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Page 2 of 11this type of artefact may have serious implications. In
clinical practice this may complicate attempts to evalu-
ate whether a health intervention or disease has resulted
in meaningful change in a person’sH R Q o L .O fn ol e s s
importance would be the effect that an inaccurate repre-
sentation of change would have during a randomised
trial if all groups were not equally exposed to stimuli
prompting a response shift[11]. For example, an inter-
vention group may be required to attend a hospital,
clinic or group intervention session resulting in expo-
sure to individuals experiencing extremely poor health
states, while a control or comparator group may not be
given this same exposure[11].
Despite the previous work by Krabbe and colleagues
on multi-item visual analogue scale ratings,[28] there is
currently no empirical evidence indicating whether an
acute shift in response to a health state scale such as
the EQ-VAS may result from a reference type bias when
individuals are rating their own health state. The pur-
pose of this study is to illustrate that respondents may
not give consistent consideration to the health states
that give meaning to the EQ-VAS, and investigate
whether merely asking respondents to consider a
detailed descriptors of an extremely good health state
(Description-A) and extremely bad health state (Descrip-
tion-B) between assessments induces an acute shift in
their own EQ-VAS rating. The set of descriptors used as
Description A and B are presented in Additional file 1.
It was hypothesized that respondents frequently would
not consider what the EQ-VAS scale anchors represent
during initial completion of this scale. Furthermore, it
was considered likely that many participants would
change their overall HRQoL report after consideration
of the extreme health descriptors (Additional file 1). It
was hypothesized that consideration of extremely poor
health descriptors would cause many respondents to
increase their reported HRQoL score as they would con-
sider their current health state to be further away from
the lower end of the scale, while some would lower
their reported HRQoL considering that their current
health state was actually closer to lower end of the
scale. In the same way after considering descriptors of
an extremely good health state many would move their
score lower, while some would move their score higher.
It was also considered possible that an order effect
may occur whereby patients’ responses may be depen-
dent not only on the extreme health state descriptors
themselves, but the order in which they were provided.
Previous investigations dealing with HRQoL reporting
and order effects have generally found no significant
order effect[35-38]. However, given the novel nature of
this investigation in providing extreme health state
descriptors between assessments, this investigation also
aimed to examine whether the order in which these
descriptors were provided affected the pattern of
responses.
Methods
Design
A two group, randomized crossover design methodology
trial was implemented (Figure 1). After completing base-
line measurements, patients randomized to group one
received Description-A first (this involved being asked
to consider the set of good health state descriptors)
then Description-B (this involved being asked to con-
sider the set of poor health state descriptors). Patients
in group two received Description-B first, then Descrip-
tion-A. There was no washout period between the pro-
vision of each of the two health state descriptor sets, as
the order effect and effect of receiving both sets of
descriptors were under investigation.
Participants and setting
One hundred and fifty-one patients admitted to the
rehabilitation unit of a tertiary hospital in Brisbane, Aus-
tralia, participated. This population was selected for this
investigation for several reasons. The focus of health
interventions for this patient group generally focuses on
treatments and therapies aiming to maximise function
and HRQoL, thus making HRQoL evaluation integral to
clinical and research assessments within this type of
patient population[3]. This population is also potentially
at risk of changing points of reference when completing
subjective patient reported outcomes due to social com-
parisons or life events that have lead them to be in need
of hospitalisation[11]. For inclusion in the study patients
were required to be able to communicate effectively in
English and have basic cognitive functioning intact as
indicated by a Mini Mental State Examination (MMSE)
score of >23/30[39].
Measures
T h ep r i m a r yo u t c o m em e a s u r ew a st h eE Q - V A S .T h i si s
ac o n t i n u o u sm e a s u r eo fo v e r a ll health state using a 100
point visual analogue scale where 0 represents the worst
imaginable health and 100 represents the best imaginable
health[18]. This outcome measure was used a total of
three times for all participants (Figure 1). The EQ-VAS
was first completed at baseline (VAS 1) as a control for
comparison purposes, then for a second time (VAS 2)
after each group had received their first set of descriptors
(Description A or B depended on group). The EQ-VAS
was then completed for a third time after the crossover
(VAS 3) after each group received the remaining set of
descriptors (Description B or A respectively).
As a secondary outcome immediately after responding
to the baseline EQ-VAS (VAS 1) before either set of
descriptors were provided, participants were asked
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imaginable health may be like.” T h i sw a sr e c o r d e da sa
binary yes/no answer for each anchor. If participants
had considered what a best imaginable or worst imagin-
able health state may be like for either EQ-VAS anchor
they were asked to describe in words what they had
considered. Their description was recorded verbatim.
After receiving each set of descriptors (Description-A or
Description-B), patients were also asked if the health
state described was more extreme than that which they
h a dp r e v i o u s l yc o n s i d e r e dt ob et h ee n dp o i n to nt h e
EQ-VAS (0 or 100 respectively). A dichotomous
response to this question (yes/no) was also recorded as
secondary outcome measure.
Baseline patient demographics and their Functional
Independence Measure score[40] were also collected
from the medical record for the purpose of describing
the sample.
Intervention (Description-A and Description-B)
Description-A involved asking the participant to con-
sider a set of descriptors for an extremely good health
Figure 1 Study design - Randomised Crossover Trial.
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the participant to consider a set of descriptors for an
extremely poor health state (Additional file 1). Each set
of descriptors required less than one minute to read at a
comfortable pace. The descriptors provided to the
patient were a compilation of the respective best and
worst descriptors for each health component used in the
Assessment of Quality of Life (AQoL) instrument[41]. It
is noteworthy that both sets of descriptors were not
intended to affect the patients underlying health, and
thus were health evaluation methodology interventions
rather than intended as any kind of clinical intervention.
The descriptors were intended to promote more careful
consideration of a range of possible HRQoL attributes
by the respondent immediately prior to assigning an
EQ-VAS value to their own health state.
Procedure
Ward staff identified potential participants who were
then approached by a research assistant (RA1). RA1
explained the study and sought informed written con-
sent. RA1 was not aware of the randomisation sequence
(calculated using computerised random number genera-
tion by a blinded member of the investigative team and
stored in a locked filing cabinet). Consenting partici-
pants were then allocated to group (one or two) in
order of the random sequence according to their partici-
pant number by a separate research assistant (RA2).
Before receiving either set of descriptors, patients in
both groups completed a baseline self-report of the EQ-
5D questionnaire including the EQ-VAS (VAS 1), and
the relevant secondary outcomes.
Group one received the health state descriptor sets in
the alternative order to group two (Figure 1). After
receiving being asked to consider the first set of health
state descriptors (Description A or B depending on
group), participants completed the assessment measures
which included a second self-report of the EQ-VAS (VAS
2) and the secondary outcome measures. Once partici-
pants had completed these assessment measures the
remaining set of health state descriptors (Description B
or A respectively) was immediately given and patients
then completed a third and final self-report of the EQ-
VAS (VAS 3) and the relevant secondary outcomes.
The assessments and health state descriptors were
administered in this way, only minutes apart, to elimi-
nate the possibility of an actual change in underlying
health state. This investigation was approved by the
Princess Alexandra Hospital and The University of
Queensland’s Human Research Ethics Committees.
Power analysis
When examining the main effect comparison of
Description-A versus Description-B on EQ-VAS scores
after each set of descriptors, this experiment had 90%
power to detect a conservative between-groups differ-
ence in VAS of 3 points assuming a standard deviation
of 17.5 using total sample size of 150 and a two tailed
alpha of 0.05. Because of the correlation of responses
within patients, this sample size had >90% power to
detect a similar change in VAS when examining the
within-group main effect of providing both sets of
descriptors between baseline (VAS 1) and the final fol-
low-up assessment (VAS 3).
Data Analysis
Demographic and baseline EQ-VAS data were tabulated
(Table 1). Raw data was checked for normality graphi-
cally and using tests for skew and kurtosis[42,43]. Differ-
ence between groups in baseline EQ-VAS score (VAS 1)
was examined using an unpaired t-test. Three change
scores for the EQ-VAS were calculated. These were the
d i f f e r e n c eb e t w e e nt h eb a s e l i n eE Q - V A Sa n dt h eE Q -
VAS completed after receiving the first set of descriptors
(VAS 2 -VAS 1), the difference between EQ-VAS after
the first set of descriptors and the final EQ-VAS after
the second set of descriptors (VAS 3 -VAS 2) and the
difference between the baseline EQ-VAS and the final
VAS after the second set of descriptors (VAS 3 -VAS 1).
The number (and percentage) of respondents who
changed their EQ-VAS by 5 points or more (in either
direction) after exposure to the good and poor health
state descriptors was calculated (Table 2). These calcula-
tions were done in order to evaluate the effect of the
health state descriptors at an individual level (as
Table 1 Participant Demographics, baseline EQ-VAS and
Functional Independence Measure scores
Group 1
n=7 7
Group 2
n=7 4
Age - median (IQR) 80 (74-86) 79 (73-86)
Mini Mental State Examination - median (IQR) 27 (25-29) 26 (25-29)
Diagnosis category
Stroke 7 (9%) 9 (12%)
Other Neurological 2 (3%) 3 (4%)
Orthopedic (non elective) 23 (30%) 20 (27%)
Orthopedic (elective) 1 (1%) 2 (3%)
Other Musculo-skeletal 2 (3%) 2 (3%)
Cardiac 3 (4%) 3 (4%)
Pulmonary 8 (10%) 5 (7%)
lower limb amputation 17 (22%) 16 (22%)
Other Medical Condition 8 (10%) 8 (11%)
Other Geriatric Condition 7 (9%) 6 (8%)
Functional Independence Measure
Cognition - median (IQR) 33 (31-34) 32 (30-33)
Motor - median (IQR) 61 (44-68) 59 (47-70)
Baseline EQ-VAS - mean (SD) 59 (19) 56 (16)
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considered important as analysis of group means would
only reflect a systematic change (i.e. a general increase
or a general decrease in EQ-VAS scores). However,
some individuals may have reported positive shifts while
others report negative shifts (depending on their
response to the health state descriptors). If shifts in
response occurred in a lessu n i f o r mw a ys u c ha st h i s ,
these changes may cancel one another out resulting in
no significant mean change. Such a finding may mask
response shifts that may have been interpreted as mean-
ingful change in a clinical setting where decisions are
likely to be based on an individual patient’sr e p o r t e d
change. This is in contrast to changes in group means
which are more likely to affect the interpretation of clin-
ical trial findings. To investigate mean EQ-VAS changes
two mixed 2x2 ANOVAs were also conducted.
The first ANOVA investigated whether providing the
good health descriptors had a different effect than provid-
ing the poor health descriptors and whether this was
dependent on the order in which the descriptors were pro-
vided. To examine this, the first ANOVA investigated the
main effects of Description (A versus B) and sequence (i.e.
whether participants were in the group who received best
or worst health descriptors first), and an interaction effect
between them. This analysis examined the change between
the EQ-VAS rating taken after respondents were exposed
to each set of health state descriptors (after Description A
or B) and the EQ-VAS rating taken immediately prior to
the provision of that set of descriptors.
The second ANOVA investigated whether the final
EQ-VAS rating after the provision of both good and
poor health state descriptors (VAS 3) was different to
the baseline EQ-VAS report (VAS 1) and whether this
was dependent on the order in which the descriptors
were provided. To examine this, the second ANOVA
investigated the main effects of total change in HRQoL
(VAS 3 -VAS 1) and sequence (i.e. group), and the
interaction between total change in HRQoL and
sequence (i.e. group).
Results
One hundred and fifty-one patients were enrolled in the
study. All participants completed each assessment and
were included in analysis. The groups’ baseline demo-
graphics were comparable (Table 1) with no mean dif-
ference in baseline EQ-VAS between groups (p = 0.30).
Immediately after completing their baseline EQ-VAS,
74 (49%) participants reported that they had not consid-
ered what best imaginable health (top scale anchor) may
be like and 85 (66%) had not considered what worst
imaginable health (bottom scale anchor) may be like. Of
those participants who did think of a best imaginable
health state, 59 (77%) thought the set of good health
descriptors (Description-A) was more extreme (better)
than the health state they had previously considered as
the top scale anchor. Of those participants who did
think of a worst imaginable health state, 63 (95%)
thought the set of poor health descriptors (Description-
B) were more extreme (worse) than the health state they
had previously considered as the bottom scale anchor.
The number of participants in each group who chan-
ged their EQ-VAS report by 5 points or more after
exposure to each of the health state descriptors are pre-
sented in Table 2. The majority of patients in both
groups either increased or decreased their VAS score
after being exposed to the good and poor health state
descriptors. When comparing the final EQ-VAS score
after both sets of health descriptors had been provided
(VAS 3), to their baseline score (VAS 1) 106 (70%) of all
participants had a final health VAS self-report that dif-
fered by 5 points or more from their baseline VAS; 51
were from group one and 55 were from group two.
The first ANOVA investigating whether providing the
good health descriptors had a different effect than pro-
viding the poor health descriptors revealed this main
effect of Description (A versus B) was significant (df =
1,149; F = 11.88; p < 0.001). A slight difference between
groups in response to the good health descriptors
observed in Figure 2 (slight increase for group one,
small decrease for group two) was not significant with
Table 2 Number of participants who increased or decreased their EQ-VAS self report by 5 points or more after
exposure to either good or poor health state descriptors as well as after both sets of descriptors
Group 1 n = 77 Group 2 n = 74
Number (%)
Increase ≥5
points
Number (%)
Decrease ≥5
points
Number (%)
Either direction
≥5points
Number (%)
Increase ≥5
points
Number (%)
Decrease ≥5
points
Number (%)
Either direction
≥5points
Good health descriptors
(Description-A)
29 (38%) 24 (31%) 53 (69%) 11 (15%) 25 (34%) 36 (49%)
Poor health descriptors
(Description-B)
37 (48%) 14 (18%) 51 (66%) 45 (61%) 8 (11%) 53 (72%)
After both Description A and B
(compared with baseline EQ-
VAS)
39 (51%) 12 (16%) 51 (66%) 40 (54%) 15 (20%) 55 (74%)
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0.623) and the interaction (df = 1,149; F = 0.07, p =
0.793) both non-significant. Data from both groups
combined indicated that the poor health descriptor set
caused a mean (SD) increase in VAS score of 4.88
(11.81) points while the good health descriptor set
caused a mean (SD) decrease in VAS score of 0.35
(10.71) points when compared with the VAS score
immediately prior to that set of descriptors.
The second ANOVA which investigated the main
effect of mean change in EQ-VAS after exposure to
both sets of descriptors (VAS 3 -VAS 1), revealed that
both groups’ final mean EQ-VAS score was higher than
their baseline EQ-VAS score (df = 1,149; F = 21.21; p <
0.001). The order in which the descriptors were received
was non-significant with the main effect of sequence
(df = 1,149; F = 2.11 p = 0.148) and the interaction
effect (df = 1,149; F = 0.13 p = 0.723) both non-signifi-
cant. The overall data from both groups combined indi-
cated a mean (SD) difference between the final EQ-VAS
(VAS 3) and the baseline EQ-VAS (VAS 1) for all parti-
cipants was 4.5 (12.0) points, VAS 3 was higher. This is
also illustrated in Figure 2 where no substantial differ-
ence between the mean change scores from each group
at the final assessment point (VAS 3) existed.
Discussion
Overall Outcome
The findings from this investigation support our hypoth-
esis that respondents frequently do not give consistent
consideration to the health states which give meaning to
a health state scale such as the EQ-VAS. This may have
a substantial effect on how a respondent reports their
HRQoL on rating scales of this nature. This investiga-
tion has been the first to demonstrate that patients’ self-
report of their own HRQoL can be substantially altered
despite no actual change in their underlying health state
occurring (Table 2 and Figure 1). A change in self
reported EQ-VAS rating was elicited for a large propor-
tion of individuals merely by asking respondents to con-
sider a set of health state descriptors (Table 2).
As one would expect, the mean baseline EQ-VAS
score (VAS 1) for this hospitalised patient sample was
substantially lower than the previously reported popula-
tion norm of 82.5 out of 100[44]. Despite anchors of
best imaginable and worst imaginable health state being
present in the standard application of this instrument,
participants frequently did not consider what these
anchors might represent. Overall 133/151 (88%) and
148/151 (98%) of participants either reported that the
descriptors of very good and very bad health states
(respectively) were more extreme than they had pre-
viously considered for the respective end anchor points
or that they had not considered best and worst imagin-
able health states at all during standard completion of
the EQ-VAS.
Overall 70% of participants changed their self-report
o fH R Q o Lo nt h e1 0 0p o i n ts c a l eb yam a r g i no f5
points or more after being provided with detailed
descriptors of both good and poor health states (Table
2). These changes were not uniform across individuals,
with 79 (52%) increasing and 27 (18%) decreasing their
EQ-VAS rating by 5 points or more.
At the present time there is no available, published
value for minimal clinically important difference on the
EQ-VAS amongst this type of population. However a
change of this magnitude is comparable to what has
previously been identified as clinically important change
on this scale amongst other patient populations[45-49].
Furthermore in the context of this population, a change
of 5 points or greater represented a change of 8.5% or
greater of the mean baseline score. Thus this amount of
change in self-reported HRQoL on this scale may well
have been interpreted as clinically meaningful for up to
70% of participants despite it being attributable to an
acute shift in response rather than a change in underly-
ing health. If this were observed in a clinical setting,
these reports may have incorrectly been interpreted as
improvement in HRQoL for individuals who increased
their score, and as decline in HRQoL amongst those
who decreased their score (Table 2).
While it is unlikely that a patient will come across
extreme health state descriptors between health assess-
ments unless they are provided to them explicitly, other
naturally occurring events (such as exposure to patients
in an extremely poor health state while attending a hos-
pital, watching television or elsewhere in the commu-
nity) are likely to affect how a respondent completes a
self evaluation of their own health state.
Figure 2 Mean difference (and standard error) from baseline at
each assessment by group.
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A strength of this investigation lies in the methodology
of employing a randomised crossover trial design for
this novel examination of HRQoL evaluation. This has
allowed for a methodologically rigorous investigation
resulting in empirical evidence to support our hypoth-
esis. This proof of concept is likely to contribute to
future improvement in self-reported health evaluation
methodology relevant to clinical settings, epidemiologi-
cal investigations and health research utilising patient
reported outcomes. However, the ability to directly gen-
eralise these results is limited by the population in this
study being hospitalised older adults and the use of a
single rating scale (EQ-VAS) as the primary outcome. It
is possible that other populations and rating scales may
have been affected to a greater or lesser extent. How-
ever, given the high use of healthcare resources by this
population and the widespread use of the EQ-5D instru-
ment, the sample and EQ-VAS were appropriate for this
investigation.
Comparison to prior research
The metric properties and theoretical basis of visual
analogue rating scales for use in evaluating health states
has been the subject of much investigation and debate
[11,28,29,50-58]. Previous empirical work has demon-
strated that EQ-VAS ratings can be dependent on the
context in which they are presented when rating multi-
ple hypothetical scenarios[28]. While that finding has
important implications regarding the use of multi-item
visual analogue scales for assigning utility values to
hypothetical health states,[28] this investigation has
been the first to highlight the risk of a reference type
bias on influencing individuals report of their own
HRQoL using a rating scale such as the EQ-VAS.
The novel nature of this investigation limits the direct
comparisons that can be made to previous empirical
investigations of the response shift phenomenon.
Research investigations in the response shift field have
often focused on analysis of mean scores or changes at
a group level [59-62] as opposed to changes at an indivi-
dual level[8,17,63]. While this investigation found signif-
icant effects at a group level with changes in mean EQ-
VAS ratings, non-uniform response shifts across a large
proportion of individuals were also observed (Table 2).
Findings from this study are consistent with previous
investigations of social comparison, framing and order
effects. It has previously been identified that self-reports
of quality of life and HRQoL are dependent on social
comparisons[64-67]. It is likely that the descriptions of
good and poor health states presented in this investiga-
tion may have elicited a similar effect to previously
described upward or downward social comparisons
respectively[64,66,67]. The resultant change in EQ-VAS
that occurred after this stimuli is also congruent with
investigations of the framing effect[30-33]. While the
current investigation did not alter the wording of the
EQ-VAS to give a positive or negative valence, a similar
effect is likely to have been elicited by the extreme
health state descriptors provided between assessments.
Interestingly, the order (sequence) in which the descrip-
tors were provided in this investigation was not statisti-
cally significant. This is consistent with previous
investigations that have revealed the order of instrument
administration to be inconsequential[35-38,68].
Implications and future directions
The EQ-VAS instrument was used in this investigation
to illustrate how variable consideration during the eva-
luation process can cause substantially different reports
of HRQoL, despite no actual change in underlying
health. Rather than an indictment of this particular
instrument (which is certainly not the intention of the
authors), these results indicate that caution should be
exercised when using subjective patient reported out-
comes such as those dependent on extreme anchors to
give meaning to the value assigned to an individual
health state.
It is clear from the minimal amount of consideration
of the anchors by the respondents during the standard
administration of the EQ-VAS, and their desire to
change their response after being asked to consider the
health state descriptors in this study, that responses are
frequently not well considered. It is possible that many
respondents may have initially applied an unwritten
qualifying context for the anchors, such as best or worst
health ‘that is possible for me,’‘ that I have experienced,’
‘for my age’, or some other social comparator. Further
investigation of what the respondents considered would
be useful to support or refute this speculation. Empirical
evidence of this nature would be useful to inform future
improvements in HRQoL evaluation methodology. This
empirical evidence could be generated through qualita-
tive analysis of a direct think aloud approach or probing
questions immediately following standard completion of
the instrument[69].
Based on findings from this investigation it may be
possible to promote consistent consideration of HRQoL
scales by artificially creating a standardised frame of
reference for an instrument. In the case of the EQ-VAS
respondents may be asked to consider a broad descrip-
tion of an extremely good and poor health state, like
those used in this study, before completing the EQ-
VAS. We are not suggesting that these health descrip-
tors represent best and worst imaginable health. Rather,
they may act as stimulus for respondents to consider a
spectrum of health components, and give reasonable
consideration to how extreme health states can be.
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sistent consideration of the instrument.
Considering the spectrum of health components
included in the health state descriptors may potentially
reduce reconceptualisation and reprioritisation, while
considering the extreme nature of how bad (or good)
each of the health components can be may help reduce
recalibration. Further investigation in this area is war-
ranted, and would most likely require use of custom
designed evaluation measures or approaches. Further
research is also indicated to determine if extreme health
states which give meaning to health rating scales are fre-
quently not considered amongst other patient popula-
tions. Investigation of the issues addressed in this
manuscript should also be examined amongst other
patient reported outcomes including pain and fatigue.
Conclusions
Subjective health state evaluations may not be well con-
sidered. An immediate significant shift in response can
be elicited by exposure to a mere description of an
extreme health state despite no actual change in under-
lying health state occurring. Caution should be exercised
when interpreting change in subjective patient reported
outcomes in research and clinical settings; particularly
those dependent on brief extreme anchors to give mean-
ing to assigned values.
Additional material
Additional file 1: Health state descriptors. This file contains the health
state descriptors used for Description-A and Description-B.
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